Method for assessing the adequacy of clinical specimens for hybridization assays and case for evaluation.

摘要

METHOD TO EVALUATE THE ADEQUACY OF CLINICAL SAMPLES FOR TESTS Hybridization and KIT FOR PERFORMING EVALUATING THE ADEQUACY OF CLINICAL SAMPLES FOR TESTS Hybridization OF nucleic acid complexes are determined according to a method comprising the following steps: (a) take A representative sample of the sample; (B) sample application, without intermediate treatment, A gel having dispersed within it A COLORING AGENT NUCLEIC ACID SO THAT THE BROKER LINK TO DYE IS Nucleic acids SAMPLE to produce a visually detectable; (C) VISUALLY DETERMINE THE AMOUNT OF DYE LINKED TO AGENT SAMPLE and compared with the result obtained from a known concentration of deoxyribonucleic acid and coloring agent TO DETERMINE THE NUMBER APPROXIMATE ASI cells in the sample. REAGENTS AND APPARATUS FOR CARRYING OUT THE METHOD CAN BE PACKAGED BY WAY OF KIT.